2020
DOI: 10.3389/fncel.2020.576037
|View full text |Cite
|
Sign up to set email alerts
|

Neuroinflammation Treatment via Targeted Delivery of Nanoparticles

Abstract: The lack of effective treatments for most neurological diseases has prompted the search for novel therapeutic options. Interestingly, neuroinflammation is emerging as a common feature to target in most CNS pathologies. Recent studies suggest that targeted delivery of small molecules to reduce neuroinflammation can be beneficial. However, suboptimal drug delivery to the CNS is a major barrier to modulate inflammation because neurotherapeutic compounds are currently being delivered systemically without spatial o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(22 citation statements)
references
References 102 publications
1
21
0
Order By: Relevance
“…A large amount of NMs have been designed and manufactured for anti-neuroinflammation, including Au NPs, ZnO NPs [ 152 ], and CeO 2 NPs [ 8 ]. The anti-neuroinflammation mechanisms of these NMs have been summarized in many reviews [ 152 , 153 ], as follows: (1) By blocking the pro-inflammatory cytokine production, including IL-1, IL-6, and TNF-α. (2) By inhibiting the activation of microglia, which are the resident brain macrophage protecting the brain from external stimulation, and is the main source of neuroinflammation [ 154 ].…”
Section: Inhibiting Rons Generation Rather Than Scavenging Ronsmentioning
confidence: 99%
See 1 more Smart Citation
“…A large amount of NMs have been designed and manufactured for anti-neuroinflammation, including Au NPs, ZnO NPs [ 152 ], and CeO 2 NPs [ 8 ]. The anti-neuroinflammation mechanisms of these NMs have been summarized in many reviews [ 152 , 153 ], as follows: (1) By blocking the pro-inflammatory cytokine production, including IL-1, IL-6, and TNF-α. (2) By inhibiting the activation of microglia, which are the resident brain macrophage protecting the brain from external stimulation, and is the main source of neuroinflammation [ 154 ].…”
Section: Inhibiting Rons Generation Rather Than Scavenging Ronsmentioning
confidence: 99%
“…Moreover, the survival rates and neurological outcomes of these animals models were improved [ 8 ]. (3) Some NMs without inherent anti-neuroinflammation can indirectly produce anti-neuroinflammation effects via delivering anti-inflammatory agents to the injured brain as a drug carrier [ 153 ].…”
Section: Inhibiting Rons Generation Rather Than Scavenging Ronsmentioning
confidence: 99%
“… 121 Applying nanoparticles to transport therapeutic substances enhances biodistribution and pharmacokinetics, permits co-delivery of several drugs, provides targeted intracellular drug delivery and decreases systemic toxicity/side effects. 122 …”
Section: Nanoformulations In Combating Neurodegeneration: Pre-clinical Evidencementioning
confidence: 99%
“…Additionally, conjugation or encapsulation of active molecules like peptides and proteins protects this fragile cargo from premature clearance or degradation by harsh physiological conditions [ 107 , 108 ]. Of course, it is critically important to choose an appropriate biomaterial and drug cargo to achieve a desired stromal, stem cell, or immune cell outcome [ 10 , 109 , 110 , 111 ]. Therapies for immunomodulation often leverage known pro- or anti-inflammatory pathways for cancer therapy and regenerative medicine, respectively.…”
Section: Biomaterials Strategies To Modulate Immune Cell Phenotypesmentioning
confidence: 99%